Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nexoptic Technology Corp V.NXO

Alternate Symbol(s):  NXOPF

NexOptic Technology Corp. is a Canada-based technology company. The Company is engaged in developing artificial intelligence (AI) and imaging products, which enhance how images are either captured, processed, experienced, transferred and/or stored. It is developing technologies relating to imagery and light concentration for lens and image capture systems. The Company's primary focus is its patented and patent pending AI for imaging called All Light Intelligent Imaging Solutions (Aliis). Aliis can reduce storage and streaming requirements needed for videos and images while also improving image quality in all types of environmental conditions. Aliis delivers by learning a camera profile and optimally enhancing, pixel by pixel, its quality and its resolution in a fraction of a second, using edge processing. Its NexCompress, a video compression enhancement solution, offers bandwidth and storage savings for video storage and streaming applications.


TSXV:NXO - Post by User

Comment by stockmonster6on Apr 14, 2021 7:36pm
87 Views
Post# 32997897

RE:RE:RE:Nexoptics = 0 respect for Shareholders

RE:RE:RE:Nexoptics = 0 respect for Shareholders Damn - not every investor is on boards like this.  in fact, I would say most don't bother with opinion boards - this is a place to vent and speculate.  Perhaps provide some article facts, but no one can tell the truth for sure except the executive; but that would be insider information.

You have to evaluate the company based on the news releases and their development.
I based my quick sell and my last loss (thank goodness I did at 43 cents!), based on the research I did off line into Pristine Surgical.

Essentially, this price decline directly relates to the lack of useful information in the NR, to me the misleading comment about 25 million procedures (of which, how much is Pristine's market share??  zero.  They have no product).  Investigating Pristine on the FDA site; as well as their own company disclaimer.

Perhaps they will make it.  Perhaps not.  NXO's profit is then tied to a company that may or may not generate sales - and of their sales what (%) is NXO's?  Well, the NR didn't say what the relationship will be.   another red flag.  no financial projections (they can't, since PS has no sales).

so you can see, all in all, despite the company's excitement about this development - the whole thing is totally moot if PS doesn't sell a thing.

Personally, as I have said, NXO, instead of waiting on a big company or working with another upstart, should have gone their own direction in developing DT with ALIIS.  This product would take the world by storm (if it is indeed as good as was indicated... still no real field tests, just images).  Once NXO had established their tech, even if it only meant a few thousand sales - other companies could have seen what they offered with their award winning tech (Edison etc...) and likely approached them.  But they did not.

Therefore, this stock suffers and so do any investors.

Until NXO can actual prove a real contact with an existing company with existing sales (or even within a Nvidia or Qualcomm), this price will not move based on their excitement about potential avenues.  Potential avenues mean nothing unless you break into the market.

So far, we have not been presented a plan with how they plan to break into the market, and a contract with Pristine Surgical is not that plan.
<< Previous
Bullboard Posts
Next >>